EPIX - ESSA Pharma to Participate in the Guggenheim Healthcare Talks 5th Annual Oncology Conference

Canada NewsWire

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Feb. 2, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will participate in a fireside chat at the Guggenheim Healthcare Talks 5th Annual Oncology Conference in New York City on Thursday, February 9, 2023 , at 9:00 a.m. Eastern Time .

David R. Parkinson , President and Chief Executive Officer of ESSA Pharma; Peter Virsik , ESSA's Chief Operating Officer; and David S. Wood , ESSA's Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com . An archived replay of the event will be available for 30 days.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma .

SOURCE ESSA Pharma Inc

View original content: http://www.newswire.ca/en/releases/archive/February2023/02/c2470.html